Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Operating Expenses (2022 - 2026)

Cannabis Bioscience International Holdings filings provide 5 years of Operating Expenses readings, the most recent being $101419.0 for Q1 2026.

  • On a quarterly basis, Operating Expenses fell 18.71% to $101419.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $496214.0, a 19.26% decrease, with the full-year FY2025 number at $684281.0, down 0.74% from a year prior.
  • Operating Expenses reached $101419.0 in Q1 2026 per CBIH's latest filing, down from $138643.0 in the prior quarter.
  • The five-year high for Operating Expenses was $311998.0 in Q1 2023, with the low at $90841.0 in Q3 2025.
  • A 5-year average of $182552.0 and a median of $154239.5 in 2023 define the central range for Operating Expenses.
  • Year-over-year, Operating Expenses tumbled 68.68% in 2024 and then soared 72.89% in 2025.
  • Year by year, Operating Expenses stood at $259099.0 in 2022, then plummeted by 44.74% to $143168.0 in 2023, then fell by 11.94% to $126072.0 in 2024, then rose by 9.97% to $138643.0 in 2025, then dropped by 26.85% to $101419.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Operating Expenses are $101419.0 (Q1 2026), $138643.0 (Q4 2025), and $90841.0 (Q3 2025).